Aerpio Pharmaceuticals, Inc. ARPO
$ 2.2
-0.9%
Aerpio Pharmaceuticals, Inc. Balance Sheet 2011-2024 | ARPO
Annual Balance Sheet Aerpio Pharmaceuticals, Inc.
2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
-42.5 M | -38.4 M | -62.6 M | -20.3 M | 166 K | 141 K | 245 K | 214 K | 165 K | 116 K |
Long Term Debt |
- | - | - | - | - | - | 125 K | 110 K | 85 K | 60 K |
Total Non Current Liabilities |
- | 67.4 K | - | - | - | - | 125 K | 110 K | 85 K | 60 K |
Total Current Liabilities |
1.87 M | 3.33 M | 5.46 M | 3.59 M | 230 K | 205 K | 160 K | 133 K | 104 K | 74.8 K |
Total Liabilities |
1.87 M | 3.4 M | 5.46 M | 3.59 M | 230 K | 205 K | 160 K | 133 K | 104 K | 74.8 K |
Deferred Revenue |
- | - | - | - | - | - | - | - | - | - |
Retained Earnings |
-147 M | -142 M | -119 M | -109 M | -276 K | -236 K | - | - | - | - |
Total Assets |
44.9 M | 39.9 M | 64.1 M | 21 M | 4.01 K | 18.5 K | 5.26 K | 8.78 K | 8.11 K | 6.62 K |
All numbers in USD currency